Urogen Pharma (URGN) Stock Chart & Stock Price History $15.41 +1.07 (+7.46%) Closing price 04:00 PM EasternExtended Trading$15.56 +0.15 (+0.94%) As of 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Urogen Pharma Stock Price Performance The Urogen Pharma (URGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 8.76%, with a year-to-date return of 44.69%. In the past month, the stock has increased 16.39%, reflecting recent market activity. As of the latest close, Urogen Pharma traded at $14.34 with a market cap of $661.17 million and volume of 775,779 shares. Five years ago, the stock traded at $25.24, representing a 38.95% decrease over that period. At the time, it had a market cap of $526.99 million and a volume of 94,600 shares. Receive URGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Urogen Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+8.22%1 Month Performance+16.39%3 Month Performance+59.36%Year-To-Date Performance+44.69%1 Year Performance-8.76%5 Year Performance-38.95% URGN Stock Chart for Thursday, July, 17, 2025 URGN Chart by TradingView Urogen Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/16/2025$14.04$14.34+2.14%$14.49$14.00775,779 shs$661.17 million07/15/2025$14.49$14.04-3.11%$14.61$13.79584,430 shs$647.38 million07/14/2025$14.24$14.49+1.76%$15.24$14.091.17 million shs$668.13 million07/11/2025$14.64$14.24-2.73%$14.64$13.91725,369 shs$656.61 million07/10/2025$13.81$14.64+6.01%$14.66$13.551.46 million shs$675.05 million07/09/2025$13.71$13.81+0.73%$14.31$13.571.58 million shs$636.74 million07/08/2025$13.49$13.71+1.63%$13.89$13.26827,939 shs$632.17 million07/07/2025$13.49$13.49$13.94$13.35745,759 shs$622.02 million07/04/2025$13.49$13.49$13.62$12.89737,414 shs$622.02 million07/03/2025$12.96$13.49+4.09%$13.62$12.89737,414 shs$622.02 million Get the Latest News and Ratings for URGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Urogen Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/02/2025$13.02$12.96-0.46%$13.64$12.731.85 million shs$597.59 million07/01/2025$13.70$13.02-4.96%$13.81$12.951.24 million shs$600.35 million06/30/2025$13.49$13.70+1.56%$13.93$13.472.10 million shs$631.67 million06/27/2025$13.11$13.49+2.90%$13.85$13.002.27 million shs$622.02 million06/26/2025$13.72$13.11-4.45%$13.75$12.872.02 million shs$604.50 million06/25/2025$13.79$13.72-0.51%$14.00$13.002.01 million shs$632.63 million06/24/2025$14.30$13.79-3.57%$14.54$13.352.48 million shs$635.86 million06/23/2025$14.65$14.30-2.39%$14.78$13.912.09 million shs$659.37 million06/20/2025$14.87$14.65-1.48%$15.61$14.323.39 million shs$675.51 million06/19/2025$14.87$14.87$15.22$13.273.97 million shs$685.66 million06/18/2025$13.24$14.87+12.31%$15.22$13.273.97 million shs$685.66 million06/17/2025$14.34$13.24-7.67%$14.57$13.114.27 million shs$610.46 million06/16/2025$12.03$14.34+19.20%$14.69$12.618.78 million shs$661.17 million Related Companies Arrowhead Pharmaceuticals Stock Chart Bausch Health Cos Stock Chart NewAmsterdam Pharma Stock Chart Apellis Pharmaceuticals Stock Chart Gemini Therapeutics Stock Chart Twist Bioscience Stock Chart Recursion Pharmaceuticals Stock Chart Agios Pharmaceuticals Stock Chart Denali Therapeutics Stock Chart Beam Therapeutics Stock Chart Receive URGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Urogen Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:URGN) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Urogen Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share Urogen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free URGN Stock Alerts